Hologic (NSDQ:HOLX) said it has launched its Definity cervical dilator for accessing uterine cavities without a tenaculum.
The device uses SureAccess balloon technology to access the cavities to lessen patient discomfort and reduce the risk of perforation during dilation, was soon to hit the market, according to the Marlborough, Mass.-based company.
The Definity dilator is designed to eliminate multiple passes and minimize false tracking, which can reduce injury to the cervix, even in patients with complex or challenging cervical anatomy. The device comes in sizes of 5mm, 7mm and 9mm. Hologic said it was developed in partnership with CrossBay Medical.
The company will be presenting the Definity dilator, along with other devices at the American Association of Gynecologic Laparoscopists annual meeting from Nov. 8 to Nov. 13.
“Physicians have been relying on dilation technology that is mostly unchanged from the original cervical dilator invented in 1879,” Hologic GYN surgical solutions VP of R&D Lucas Churchill said in a news release. “We’re committed to identifying unmet needs of our customers and are proud to deliver significant advancements to one of the most commonly used devices in gynecology. In addition, the Definity dilator is a great example of our ability to leverage strategic partnerships to deliver technological innovations that advance women’s health.”
“Physicians frequently encounter variable cervical anatomy, which can create risk and increase discomfort for patients and time delay with procedures,” Hologic medical director & VP of global medical affairs Dr. Edward Evantash. “The Definity dilator is an innovative alternative to fixed-size dilators for a range of intrauterine procedures. This gives physicians more confidence in the dilation process so they can focus on their procedures, not accessing the cavity.”
Shares of HOLX were up 1.8% at $48.99 per share in mid-afternoon trading today.